Cargando…

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients

BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasano, Alfonso, Fung, Victor S. C., Lopiano, Leonardo, Elibol, Bulent, Smolentseva, Irina G., Seppi, Klaus, Takáts, Annamária, Onuk, Koray, Parra, Juan Carlos, Bergmann, Lars, Sail, Kavita, Jalundhwala, Yash, Pirtosek, Zvezdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444751/
https://www.ncbi.nlm.nih.gov/pubmed/30940119
http://dx.doi.org/10.1186/s12883-019-1276-8
_version_ 1783408078323974144
author Fasano, Alfonso
Fung, Victor S. C.
Lopiano, Leonardo
Elibol, Bulent
Smolentseva, Irina G.
Seppi, Klaus
Takáts, Annamária
Onuk, Koray
Parra, Juan Carlos
Bergmann, Lars
Sail, Kavita
Jalundhwala, Yash
Pirtosek, Zvezdan
author_facet Fasano, Alfonso
Fung, Victor S. C.
Lopiano, Leonardo
Elibol, Bulent
Smolentseva, Irina G.
Seppi, Klaus
Takáts, Annamária
Onuk, Koray
Parra, Juan Carlos
Bergmann, Lars
Sail, Kavita
Jalundhwala, Yash
Pirtosek, Zvezdan
author_sort Fasano, Alfonso
collection PubMed
description BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analysis was to determine the proportion of APD vs. non-advanced PD (non-APD) patients attending specialist PD clinics and to demonstrate the clinical burden of APD. METHODS: OBSERVE-PD, a cross-sectional, international, observational study, was conducted with 2615 PD patients at 128 movement disorder centers in 18 countries. Motor and non-motor symptoms, activities of daily living, and quality-of-life end points were assessed. The correlation between physician’s global assessment of advanced PD and the advanced PD criteria from a consensus of an international group of experts (Delphi criteria for APD) were evaluated. RESULTS: According to physician’s judgment, 51% of patients were considered to have APD. There was a moderate correlation between physician’s judgment and Delphi criteria for APD (K = 0.430; 95% CI 0.406–0.473). Activities of daily living, motor symptom severity, dyskinesia duration/disability, “Off” time duration, non-motor symptoms, and quality-of-life scores were worse among APD vs. non-APD patients (p < 0.0001 for all). APD patients (assessed by physicians) had higher disease burden by motor and non-motor symptoms compared with non-APD patients and a negative impact on activities of daily living and quality of life. CONCLUSIONS: These findings aid in identifying standard APD classification parameters for use in practicing physicians. Improvements in identification of APD patients may be particularly relevant for optimizing treatment strategies including transitioning to device-aided treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1276-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6444751
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64447512019-04-12 Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients Fasano, Alfonso Fung, Victor S. C. Lopiano, Leonardo Elibol, Bulent Smolentseva, Irina G. Seppi, Klaus Takáts, Annamária Onuk, Koray Parra, Juan Carlos Bergmann, Lars Sail, Kavita Jalundhwala, Yash Pirtosek, Zvezdan BMC Neurol Research Article BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analysis was to determine the proportion of APD vs. non-advanced PD (non-APD) patients attending specialist PD clinics and to demonstrate the clinical burden of APD. METHODS: OBSERVE-PD, a cross-sectional, international, observational study, was conducted with 2615 PD patients at 128 movement disorder centers in 18 countries. Motor and non-motor symptoms, activities of daily living, and quality-of-life end points were assessed. The correlation between physician’s global assessment of advanced PD and the advanced PD criteria from a consensus of an international group of experts (Delphi criteria for APD) were evaluated. RESULTS: According to physician’s judgment, 51% of patients were considered to have APD. There was a moderate correlation between physician’s judgment and Delphi criteria for APD (K = 0.430; 95% CI 0.406–0.473). Activities of daily living, motor symptom severity, dyskinesia duration/disability, “Off” time duration, non-motor symptoms, and quality-of-life scores were worse among APD vs. non-APD patients (p < 0.0001 for all). APD patients (assessed by physicians) had higher disease burden by motor and non-motor symptoms compared with non-APD patients and a negative impact on activities of daily living and quality of life. CONCLUSIONS: These findings aid in identifying standard APD classification parameters for use in practicing physicians. Improvements in identification of APD patients may be particularly relevant for optimizing treatment strategies including transitioning to device-aided treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1276-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-02 /pmc/articles/PMC6444751/ /pubmed/30940119 http://dx.doi.org/10.1186/s12883-019-1276-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fasano, Alfonso
Fung, Victor S. C.
Lopiano, Leonardo
Elibol, Bulent
Smolentseva, Irina G.
Seppi, Klaus
Takáts, Annamária
Onuk, Koray
Parra, Juan Carlos
Bergmann, Lars
Sail, Kavita
Jalundhwala, Yash
Pirtosek, Zvezdan
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title_full Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title_fullStr Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title_full_unstemmed Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title_short Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
title_sort characterizing advanced parkinson’s disease: observe-pd observational study results of 2615 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444751/
https://www.ncbi.nlm.nih.gov/pubmed/30940119
http://dx.doi.org/10.1186/s12883-019-1276-8
work_keys_str_mv AT fasanoalfonso characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT fungvictorsc characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT lopianoleonardo characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT elibolbulent characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT smolentsevairinag characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT seppiklaus characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT takatsannamaria characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT onukkoray characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT parrajuancarlos characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT bergmannlars characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT sailkavita characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT jalundhwalayash characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients
AT pirtosekzvezdan characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients